Category: Products

High Times Publisher Josh Kesselman Just Made the Forbes Cannabis List. It Started With a Magazine Smuggled Under His Jacket at 16.

Josh Kesselman bought his first copy of High Times at 16, smuggled it under his jacket out of a New York City shop and read it cover to cover twice. Forty years later, he owns it, and Forbes just named him one of the 42 people shaping the legal cannabis industry. You can tell the […]

Psychedelic Reform Is Spreading Faster Than Anyone Expected. The Movement Is Trying Not to Blow It.

Psychedelic legislation is moving through more state capitols simultaneously than at any point in history. The question is not whether reform is coming. It is whether it will be done right. In March 2026, Oregon signed into law significant modifications to its psilocybin services program, the first regulated psychedelic access system in the country, now […]

How Free Do You Actually Feel as a Cannabis Consumer? NORML Wants to Know

Forget what your state’s law says on paper. NORML’s new Cannabis Freedom Survey asks the question that actually matters: how free do you feel? Laws on the books and lived reality are two different things. You can be in a legal state and still worry about your job, your landlord, your custody arrangement or a […]

The Real Cost of Cannabis Prohibition

Cannabis reform is often framed as a business or cultural issue. In reality, cannabis policy goes far beyond dispensaries; it touches the health, security, and financial stability of every American family. Decisions on cannabis policy shape who can access medicine, how communities are protected, and whether hardworking people can maintain stable livelihoods.  Photo courtesy of […]

Everything You Know About CBD Is Probably Wrong

By Michael Krawitz with the assistance of the Veterans Action Council. For many decades, those of us working at the intersection of Veteran healthcare, medical cannabis advocacy, and international drug policy have encountered the same response from the DEA that the international treaties allow the DEA, up until now, to block medical access to cannabis. […]

Back To Top